39 results
S-8
PTPI
Petros Pharmaceuticals Inc
22 Dec 22
Registration of securities for employees
5:03pm
.
Represents shares of Common Stock available for issuance pursuant to unissued equity awards under the 2020 Plan.
The Registrant does not have any fee offsets.
Table 2— Fee Offset Claims and Sources
N/A
POS AM
PTPI
Petros Pharmaceuticals Inc
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
, and (iii) 110,000 shares of common stock that may be sold by the selling stockholders named herein upon the exercise of the Katalyst Warrants.
Table 2: Fee Offset Claims and Sources
N/A
Table 3: Combined Prospectuses
N/A
8-K/A
EX-99.1
f2gazzpi1967u76yud6
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-10.3
jywsq3w 0gaabk
21 Jan 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
ek7gwf022q e8k1b
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
10-Q
eyul1tbj
14 May 21
Quarterly report
4:31pm
424B3
xrhjlob9
14 Jan 22
Prospectus supplement
5:18pm
8-K
EX-99.1
1i4ul6r66d0hj5
16 Nov 21
Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
12:00am